Abbreviations5MeC5‐methylcytidineAGEAdvanced glycation end productsRAGEAdvanced glycation end products receptorAMPKAMP‐activated protein kinaseBcl‐2Anti‐apoptotic proteinC1Control animals of short‐term experimentC2Control animals of long‐term experimentM1Control animals treated with MLT of short‐term experimentM2Control animals treated with MLT of short‐term experimentDMDiabetes mellitusDABDiaminobenzidineGLUT2Glucose transporter type 2GSTPIGlutathione S‐transferase piPINIntraepithelial neoplasiaLHLuteinizing hormoneMLTMelatoninMTR1Melatonin receptor type 1D1One‐week‐diabetic ratsMD1One‐week‐diabetic rats treated with MLTPCNAProliferating cell nuclear antigenPIAProliferative inflammatory atrophyPINProstate intraepithelial neoplasiaPKAProtein kinases APKBProtein kinases BPKCProtein kinases CROSReactive oxygen speciessmcSmooth muscle cellsSTZStreptozotocinD2Two‐month‐diabetic ratsMD2Two‐month‐diabetic rats treated with MLT.IntroductionThe association between diabetes mellitus (DM) and prostate cancer is controversial. Some clinical studies have associated DM, especially type‐1, with a lower risk of prostate cancer, attributed to the protective effects of insulin lack and lower testosterone levels (Moreira et al., ; Fall et al., ; Xu et al., ; Yu et al., ). This is due because insulin regulates the production of testosterone by affecting the hypothalamic‐hypophyseal‐testes axis (Kirchick et al., ) and producing local effects through insulin receptors (Bhasin et al., ; Cáp, ). Insulin‐like growth factor 1 (IGF‐1) was identified as a major regulator of epithelial cell survival in the rat ventral prostate (Ohlson et al., ). On the other hand, poor glycemic control has been associated with higher risk of prostate cancer (Ishiguro et al.,
Cell Biology International – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”
Daniel C.
“Whoa! It’s like Spotify but for academic articles.”
@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”
@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”
@JoseServera
$49/month
14-day Free Trial
$588
$360/year
14-day Free Trial
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.